Cargando…

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity

Systemic lupus erythematosus (SLE) and other autoimmune diseases are propelled by immune dysregulation and pathogenic, disease-specific autoantibodies. Autoimmunity against the lupus autoantigen Sm is associated with cross-reactivity to Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA-1). Additional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munroe, Melissa E., Anderson, Jourdan R., Gross, Timothy F., Stunz, Laura L., Bishop, Gail A., James, Judith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886997/ https://www.ncbi.nlm.nih.gov/pubmed/33613527 http://dx.doi.org/10.3389/fimmu.2020.606936

Ejemplares similares

Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus
por: Jog, Neelakshi R., et al.
Publicado: (2021)

Epstein-Barr Virus and Systemic Lupus Erythematosus
por: Draborg, Anette Holck, et al.
Publicado: (2012)

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk individuals
por: Jog, Neelakshi R., et al.
Publicado: (2019)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients
por: Draborg, Anette Holck, et al.
Publicado: (2016)

Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients
por: Draborg, Anette Holck, et al.
Publicado: (2014)

Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus
por: Chen, Xiaotong, et al.
Publicado: (2023)

Patients with systemic lupus erythematosus have abnormally elevated Epstein–Barr virus load in blood
por: Moon, Uk Yeol, et al.
Publicado: (2004)

Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
por: Lossius, Andreas, et al.
Publicado: (2012)

Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions
por: Buonavoglia, Alessio, et al.
Publicado: (2021)

Age-related Epstein-Barr Virus-associated Lymphoproliferative Disorder Masquerading as Systemic Lupus Erythematosus
por: Kadoba, Keiichiro, et al.
Publicado: (2021)

The Possible Effect of B-Cell Epitopes of Epstein–Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus
por: Tu, Jianxin, et al.
Publicado: (2018)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Epstein-Barr Virus in Systemic Autoimmune Diseases
por: Draborg, Anette Holck, et al.
Publicado: (2013)

Epstein-Barr Virus and Systemic Autoimmune Diseases
por: Houen, Gunnar, et al.
Publicado: (2021)

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus
por: Hanlon, Peter, et al.
Publicado: (2014)

The risk of systemic lupus erythematosus associated with Epstein–Barr virus infection: a systematic review and meta-analysis
por: Li, Zhao-Xia, et al.
Publicado: (2018)

Autoimmune Retinopathy in Systemic Lupus Erythematosus: Histopathologic Features
por: Cao, Xiaoguang, et al.
Publicado: (2009)

The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB
por: Zuo, Lielian, et al.
Publicado: (2015)

Correlation between Epstein-Barr Virus Infection and Disease Activity of Systemic Lupus Erythematosus: a Cross-Sectional Study
por: Piroozmand, Ahmad, et al.
Publicado: (2017)

Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus
por: Larsen, Martin, et al.
Publicado: (2011)

Lymphocytic Interstitial Pneumonitis Associated with Epstein-Barr virus in Systemic Lupus Erythematosus and Sjögren’s Syndrome.: Complete remission with corticosteroid and cyclophosphamide
por: Yum, Ho-Kee, et al.
Publicado: (2002)

Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus
por: Wood, Rebecca A., et al.
Publicado: (2021)

Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function
por: Chang, Rhoda A., et al.
Publicado: (2012)

Systemic Lupus Erythematosus and Thyroid Autoimmunity
por: Ferrari, Silvia Martina, et al.
Publicado: (2017)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases
por: Rigopoulou, Eirini I., et al.
Publicado: (2012)

Epstein–Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement
por: Miskovic, Rada, et al.
Publicado: (2023)

Differential Signaling and Tumor Necrosis Factor Receptor–Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1)
por: Brown, Kevin D., et al.
Publicado: (2001)

Latent orbital pseudotumor secondary to systemic lupus erythematosus
por: Rico, María, et al.
Publicado: (2016)

High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma
por: Ryan, Julie L., et al.
Publicado: (2008)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

The Epstein–Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins
por: Coppotelli, Giuseppe, et al.
Publicado: (2013)

Plasma Epstein–Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses
por: Sinha, Mahua, et al.
Publicado: (2016)

Spontaneous metastases in immunocompetent mice harboring a primary tumor driven by oncogene latent membrane protein 1 from Epstein–Barr virus
por: Chang, Pu-Yuan, et al.
Publicado: (2016)

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site
por: Csorba, Kinga, et al.
Publicado: (2019)

Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma
por: Zhu, Qian-Ying
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gkuqrat7rf2lr441bsa7kq57ep